Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3546 |
|
| Actual shortage: | 240 (7%) | |
| Anticipated shortage: | 3 (0%) | |
| Avoided shortage: | 11 (0%) | |
| Resolved: | 3292 (93%) | |
Discontinuation Reports |
366 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 342 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
32 (12%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-LEFLUNOMIDE | 10MG | TABLET | Resolved | 2017-03-11 | 2017-05-23 | 667 |
| APO-LEFLUNOMIDE | 10MG | TABLET | Resolved | 2019-11-27 | 2020-03-13 | 99786 |
| APO-LEFLUNOMIDE | 20MG | TABLET | Resolved | 2019-11-27 | 2020-03-13 | 99789 |
| APO-LEFLUNOMIDE | 10MG | TABLET | Resolved | 2022-11-11 | 2023-01-20 | 174338 |
| APO-LEFLUNOMIDE | 20MG | TABLET | Resolved | 2022-12-16 | 2023-01-20 | 178748 |
| APO-LEFLUNOMIDE | 20MG | TABLET | Resolved | 2023-05-12 | 2023-06-02 | 192367 |
| APO-LEFLUNOMIDE | 10MG | TABLET | Resolved | 2023-09-22 | 2023-11-10 | 205009 |
| APO-LEFLUNOMIDE | 10MG | TABLET | Resolved | 2024-01-19 | 2024-02-09 | 216659 |
| APO-LEFLUNOMIDE | 20MG | TABLET | Resolved | 2024-04-26 | 2024-05-31 | 226315 |
| APO-LENALIDOMIDE | 20MG | CAPSULE | Resolved | 2023-10-20 | 2023-12-01 | 207695 |
| APO-LETROZOLE | 2.5MG | TABLET | Resolved | 2017-03-17 | 2017-07-20 | 3169 |
| APO-LETROZOLE | 2.5MG | TABLET | Resolved | 2019-05-08 | 2020-11-25 | 83518 |
| APO-LETROZOLE | 2.5MG | TABLET | Resolved | 2022-09-01 | 2022-09-16 | 168415 |
| APO-LETROZOLE | 2.5MG | TABLET | Resolved | 2023-03-09 | 2023-03-16 | 186589 |
| APO-LETROZOLE | 2.5MG | TABLET | Resolved | 2024-03-22 | 2024-04-12 | 223043 |
| APO-LETROZOLE | 2.5MG | TABLET | Resolved | 2024-07-12 | 2024-09-06 | 232838 |
| APO-LETROZOLE | 2.5MG | TABLET | Resolved | 2024-10-18 | 2024-11-08 | 240694 |
| APO-LEVETIRACETAM | 500MG | TABLET | Resolved | 2017-07-26 | 2018-03-15 | 17251 |
| APO-LEVETIRACETAM | 750MG | TABLET | Resolved | 2017-10-03 | 2018-03-15 | 24262 |
| APO-LEVETIRACETAM | 250MG | TABLET | Resolved | 2018-03-05 | 2018-06-08 | 41852 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MELPHALAN FOR INJECTION | 10ML 50MG | POWDER FOR SOLUTION KIT SOLUTION | Discontinued | 2022-03-23 | 2022-03-23 | 157136 |
| NAPROXEN SODIUM TABLETS | 220MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71228 |
| APO-PENTOXIFYLLINE SR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-23 | 2022-01-27 | 65438 |
| APO-TEMAZEPAM | 15MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65477 |
| APO-TEMAZEPAM | 30MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-07 | 65482 |
| TIGECYCLINE | 50MG | POWDER FOR SOLUTION | To be discontinued | 2019-06-21 | 2019-06-21 | 87218 |